ResMed Inc (BSP:R1MD34)
R$ 381 9.84 (2.65%) Market Cap: 223.72 Bil Enterprise Value: 226.25 Bil PE Ratio: 32.98 PB Ratio: 7.04 GF Score: 86/100

Resmed Inc at Sanford C Bernstein Strategic Decisions Conference Transcript

Jun 01, 2022 / 05:30PM GMT
Release Date Price: R$243.12
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

We are ready to go. Thanks, everybody, for joining. I'm Lee Hambright, U.S. medical devices analyst at Bernstein, and we are thrilled to host Mick Farrell, ResMed's CEO. We are scheduled for a 50-minute fireside chat. Just a reminder, you can submit questions anytime through Pigeonhole, or you can raise your hand and we can get them in that way.

So Mick, we really appreciate you joining us. Thanks for being here.

Michael J. Farrell
ResMed Inc. - CEO & Director

I'm happy to be here.

Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

So you've served as ResMed's CEO for nearly a decade. Very happy to welcome you here to SDC. I think we'll jump right into Q&A.

Questions & Answers

Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

Maybe just starting at a very high level. You

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot